Ilyichev, A. A., Orlova, L. A., Sharabrin, S. V., & Karpenko, L. I. (2020). mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development. Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences.
Styl ChicagoIlyichev, A. A., L. A. Orlova, S. V. Sharabrin, a L. I. Karpenko. MRNA Technology As One of the Promising Platforms for the SARS-CoV-2 Vaccine Development. Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences, 2020.
Citace podle MLAIlyichev, A. A., L. A. Orlova, S. V. Sharabrin, a L. I. Karpenko. MRNA Technology As One of the Promising Platforms for the SARS-CoV-2 Vaccine Development. Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences, 2020.